GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MaxCyte Inc (STU:MYE0) » Definitions » Price-to-Tangible-Book

MaxCyte (STU:MYE0) Price-to-Tangible-Book : 1.94 (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is MaxCyte Price-to-Tangible-Book?

As of today (2024-06-05), MaxCyte's share price is €3.88. MaxCyte's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €2.00. Hence, MaxCyte's Price to Tangible Book Ratio of today is 1.94.

The historical rank and industry rank for MaxCyte's Price-to-Tangible-Book or its related term are showing as below:

STU:MYE0' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.4   Med: 4.93   Max: 14.63
Current: 2.05

During the past 12 years, MaxCyte's highest Price to Tangible Book Ratio was 14.63. The lowest was 1.40. And the median was 4.93.

STU:MYE0's Price-to-Tangible-Book is ranked better than
60.54% of 702 companies
in the Medical Devices & Instruments industry
Industry Median: 2.685 vs STU:MYE0: 2.05

A closely related ratio is called PB Ratio. As of today, MaxCyte's share price is €3.88. MaxCyte's Book Value per Sharefor the quarter that ended in Mar. 2024 was €2.00. Hence, MaxCyte's P/B Ratio of today is 1.94.


MaxCyte Price-to-Tangible-Book Historical Data

The historical data trend for MaxCyte's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MaxCyte Price-to-Tangible-Book Chart

MaxCyte Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 3.74 2.13 1.92

MaxCyte Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.74 1.83 1.29 1.92 1.90

Competitive Comparison of MaxCyte's Price-to-Tangible-Book

For the Medical Devices subindustry, MaxCyte's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MaxCyte's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MaxCyte's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where MaxCyte's Price-to-Tangible-Book falls into.



MaxCyte Price-to-Tangible-Book Calculation

MaxCyte's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=3.88/1.995
=1.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


MaxCyte Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of MaxCyte's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


MaxCyte (STU:MYE0) Business Description

Traded in Other Exchanges
Address
9713 Key West Avenue, Suite 400, Rockville, MD, USA, 20850
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

MaxCyte (STU:MYE0) Headlines

No Headlines